Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2895018213', 'doi': 'https://doi.org/10.3389/fimmu.2018.02434', 'title': 'Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis', 'display_name': 'Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis', 'publication_year': 2018, 'publication_date': '2018-10-23', 'ids': {'openalex': 'https://openalex.org/W2895018213', 'doi': 'https://doi.org/10.3389/fimmu.2018.02434', 'mag': '2895018213', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30405628', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/6207051'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fimmu.2018.02434', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fimmu.2018.02434/pdf', 'source': {'id': 'https://openalex.org/S2595292759', 'display_name': 'Frontiers in Immunology', 'issn_l': '1664-3224', 'issn': ['1664-3224'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.frontiersin.org/articles/10.3389/fimmu.2018.02434/pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101868685', 'display_name': 'Swati Bhattacharyya', 'orcid': 'https://orcid.org/0000-0002-4005-5896'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Swati Bhattacharyya', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100688152', 'display_name': 'Wenxia Wang', 'orcid': 'https://orcid.org/0000-0003-4681-8783'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Wenxia Wang', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069895972', 'display_name': 'Zenshiro Tamaki', 'orcid': 'https://orcid.org/0000-0001-5706-9883'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zenshiro Tamaki', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073610752', 'display_name': 'Bo Shi', 'orcid': 'https://orcid.org/0000-0002-0780-0372'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bo Shi', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076453661', 'display_name': 'Anjana V. Yeldandi', 'orcid': 'https://orcid.org/0000-0001-9593-5375'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anjana Yeldandi', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005554045', 'display_name': 'Yasuhiro Tsukimi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I44892455', 'display_name': 'Takeda (Japan)', 'ror': 'https://ror.org/04hjbmv12', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I44892455']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yasuhiro Tsukimi', 'raw_affiliation_strings': ['Takeda Pharmaceutical Company Limited, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Takeda Pharmaceutical Company Limited, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I44892455']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024782459', 'display_name': 'Masashi Yamasaki', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I44892455', 'display_name': 'Takeda (Japan)', 'ror': 'https://ror.org/04hjbmv12', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I44892455']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masashi Yamasaki', 'raw_affiliation_strings': ['Takeda Pharmaceutical Company Limited, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Takeda Pharmaceutical Company Limited, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I44892455']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5012966437', 'display_name': 'John Varga', 'orcid': 'https://orcid.org/0000-0001-8400-687X'}, 'institutions': [{'id': 'https://openalex.org/I4210141498', 'display_name': 'Scleroderma Foundation', 'ror': 'https://ror.org/04g20q935', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210141498']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'John Varga', 'raw_affiliation_strings': ['Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States'], 'affiliations': [{'raw_affiliation_string': 'Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States', 'institution_ids': ['https://openalex.org/I4210141498']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5101868685', 'https://openalex.org/A5012966437'], 'corresponding_institution_ids': ['https://openalex.org/I4210141498', 'https://openalex.org/I4210141498'], 'apc_list': {'value': 2950, 'currency': 'USD', 'value_usd': 2950, 'provenance': 'doaj'}, 'apc_paid': {'value': 2950, 'currency': 'USD', 'value_usd': 2950, 'provenance': 'doaj'}, 'fwci': 5.427, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 50, 'citation_normalized_percentile': {'value': 0.873706, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '9', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11330', 'display_name': 'Pathogenesis and Treatment of Systemic Sclerosis', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11330', 'display_name': 'Pathogenesis and Treatment of Systemic Sclerosis', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10870', 'display_name': 'Idiopathic Pulmonary Fibrosis: Diagnosis and Management', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13313', 'display_name': "Treatment and Pathogenesis of Dupuytren's Disease", 'score': 0.9876, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/myofibroblast', 'display_name': 'Myofibroblast', 'score': 0.77134126}, {'id': 'https://openalex.org/keywords/tgf-ß-signaling', 'display_name': 'TGF-ß Signaling', 'score': 0.52153}, {'id': 'https://openalex.org/keywords/tgf-ß1-stimulation', 'display_name': 'TGF-ß1 Stimulation', 'score': 0.511344}], 'concepts': [{'id': 'https://openalex.org/C2780559512', 'wikidata': 'https://www.wikidata.org/wiki/Q605709', 'display_name': 'Fibrosis', 'level': 2, 'score': 0.8380661}, {'id': 'https://openalex.org/C207865475', 'wikidata': 'https://www.wikidata.org/wiki/Q1467330', 'display_name': 'Myofibroblast', 'level': 3, 'score': 0.77134126}, {'id': 'https://openalex.org/C2776070231', 'wikidata': 'https://www.wikidata.org/wiki/Q14914098', 'display_name': 'TLR4', 'level': 3, 'score': 0.6810398}, {'id': 'https://openalex.org/C2776232574', 'wikidata': 'https://www.wikidata.org/wiki/Q415571', 'display_name': 'Bleomycin', 'level': 3, 'score': 0.6333385}, {'id': 'https://openalex.org/C2781244666', 'wikidata': 'https://www.wikidata.org/wiki/Q32446', 'display_name': 'Pulmonary fibrosis', 'level': 3, 'score': 0.59391797}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.49730685}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4942086}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.48338193}, {'id': 'https://openalex.org/C2778341716', 'wikidata': 'https://www.wikidata.org/wiki/Q2290446', 'display_name': 'Idiopathic pulmonary fibrosis', 'level': 3, 'score': 0.45470884}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.40681297}, {'id': 'https://openalex.org/C2777714996', 'wikidata': 'https://www.wikidata.org/wiki/Q7886', 'display_name': 'Lung', 'level': 2, 'score': 0.38177314}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.34906477}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.32360134}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.16828644}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.05882767}], 'mesh': [{'descriptor_ui': 'D005347', 'descriptor_name': 'Fibroblasts', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D011658', 'descriptor_name': 'Pulmonary Fibrosis', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D012595', 'descriptor_name': 'Scleroderma, Systemic', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D012867', 'descriptor_name': 'Skin', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': True}, {'descriptor_ui': 'D051197', 'descriptor_name': 'Toll-Like Receptor 4', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002478', 'descriptor_name': 'Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005347', 'descriptor_name': 'Fibroblasts', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005355', 'descriptor_name': 'Fibrosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008809', 'descriptor_name': 'Mice, Inbred C3H', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008822', 'descriptor_name': 'Mice, Transgenic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011658', 'descriptor_name': 'Pulmonary Fibrosis', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D011658', 'descriptor_name': 'Pulmonary Fibrosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012595', 'descriptor_name': 'Scleroderma, Systemic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012867', 'descriptor_name': 'Skin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051197', 'descriptor_name': 'Toll-Like Receptor 4', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D051197', 'descriptor_name': 'Toll-Like Receptor 4', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D051197', 'descriptor_name': 'Toll-Like Receptor 4', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fimmu.2018.02434', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fimmu.2018.02434/pdf', 'source': {'id': 'https://openalex.org/S2595292759', 'display_name': 'Frontiers in Immunology', 'issn_l': '1664-3224', 'issn': ['1664-3224'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc6207051', 'pdf_url': 'https://europepmc.org/articles/pmc6207051?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207051', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30405628', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fimmu.2018.02434', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fimmu.2018.02434/pdf', 'source': {'id': 'https://openalex.org/S2595292759', 'display_name': 'Frontiers in Immunology', 'issn_l': '1664-3224', 'issn': ['1664-3224'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.81, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1518950845', 'https://openalex.org/W1966676847', 'https://openalex.org/W2001518113', 'https://openalex.org/W2009425970', 'https://openalex.org/W20377036', 'https://openalex.org/W2045142779', 'https://openalex.org/W2053189438', 'https://openalex.org/W2056812842', 'https://openalex.org/W2112763983', 'https://openalex.org/W2125874167', 'https://openalex.org/W2158591358', 'https://openalex.org/W2171043642', 'https://openalex.org/W2411779324', 'https://openalex.org/W2473350718', 'https://openalex.org/W2515969612', 'https://openalex.org/W2590029470', 'https://openalex.org/W2612060684', 'https://openalex.org/W2735948539', 'https://openalex.org/W2760109000', 'https://openalex.org/W2775471009', 'https://openalex.org/W4211001791', 'https://openalex.org/W4211149849', 'https://openalex.org/W4233799263'], 'related_works': ['https://openalex.org/W4280648639', 'https://openalex.org/W3196482013', 'https://openalex.org/W307228711', 'https://openalex.org/W2383309780', 'https://openalex.org/W2380651012', 'https://openalex.org/W2365811023', 'https://openalex.org/W2364204753', 'https://openalex.org/W2359640985', 'https://openalex.org/W2121729413', 'https://openalex.org/W2102239057'], 'abstract_inverted_index': {'Systemic': [0], 'sclerosis': [1], '(SSc)': [2], 'is': [3], 'a': [4, 19, 80, 93, 171], 'poorly': [5], 'understood': [6], 'heterogeneous': [7], 'condition': [8], 'with': [9, 53, 57], 'progressive': [10, 72], 'multi-organ': [11], 'fibrosis.': [12, 74, 86, 166], 'Recent': [13], 'genetic': [14, 62], 'and': [15, 26, 48, 55, 102, 114, 117, 130, 143, 179], 'genomic': [16], 'evidence': [17], 'suggest': [18], 'pathogenic': [20], 'role': [21], 'for': [22, 174], 'dysregulated': [23], 'innate': [24], 'immunity': [25], 'toll-like': [27], 'receptor': [28], '(TLR)': [29], 'activity': [30], 'in': [31, 46, 98, 103, 135, 146, 161], 'SSc.': [32], 'Levels': [33], 'of': [34, 64, 91, 121, 164, 177], 'both': [35], 'TLR4,': [36], 'as': [37, 39, 157], 'well': [38], 'certain': [40], 'endogenous': [41, 68], 'TLR': [42], 'ligands,': [43], 'are': [44], 'elevated': [45], 'skin': [47], 'lung': [49], 'tissues': [50], 'from': [51], 'patients': [52], 'SSc': [54, 104, 150, 178], 'correlate': [56], 'clinical': [58], 'disease': [59], 'parameters.': [60], 'Conversely,': [61], 'targeting': [63], 'TLR4': [65, 76, 96], 'or': [66], 'its': [67], '"damage-associated"': [69], 'ligands': [70], 'ameliorates': [71], 'tissue': [73], 'Targeting': [75], 'signaling': [77], 'therefore': [78], 'represents': [79], 'pharmacological': [81], 'strategy': [82, 173], 'to': [83], 'prevent': [84], 'intractable': [85], 'We': [87], 'examined': [88], 'the': [89, 119, 175], 'effect': [90], 'TAK242,': [92], 'small': [94], 'molecule': [95], 'inhibitor,': [97], 'preclinical': [99, 162], 'fibrosis': [100, 129], 'models': [101, 163], 'fibroblasts.': [105], 'TAK242': [106, 126, 139, 156, 167], 'treatment': [107, 176], 'prevented,': [108], 'promoted': [109], 'regression': [110], 'of,': [111], 'bleomycin-induced': [112], 'dermal': [113], 'pulmonary': [115], 'fibrosis,': [116], 'reduced': [118, 131], 'expression': [120], 'several': [122], 'pro-fibrotic': [123], 'mediators.': [124], 'Furthermore,': [125], 'ameliorated': [127], 'peritoneal': [128], 'spontaneous': [132], 'hypodermal': [133], 'thickness': [134], 'TSK/+': [136], 'mice.': [137], 'Importantly,': [138], 'abrogated': [140], 'collagen': [141], 'synthesis': [142], 'myofibroblasts': [144], 'differentiation': [145], 'explanted': [147], 'constitutively': [148], 'active': [149], 'fibroblast.': [151], 'Altogether,': [152], 'these': [153], 'findings': [154], 'identify': [155], 'an': [158], 'anti-fibrotic': [159], 'agent': [160], 'organ': [165], 'might': [168], 'potentially': [169], 'represent': [170], 'novel': [172], 'other': [180], 'fibrotic': [181], 'diseases.': [182]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2895018213', 'counts_by_year': [{'year': 2024, 'cited_by_count': 5}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 7}, {'year': 2021, 'cited_by_count': 10}, {'year': 2020, 'cited_by_count': 14}, {'year': 2019, 'cited_by_count': 4}], 'updated_date': '2024-09-14T19:52:36.165075', 'created_date': '2018-10-12'}